Life Science Company News

Results 261 - 280 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

By: GlobeNewswire - 24 Apr 2024

Related companies: Novartis AG | Novan, Inc.

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

By: GlobeNewswire - 24 Apr 2024

Related companies: F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

By: GlobeNewswire - 24 Apr 2024

Related companies: Vivoryon Therapeutics N.V.

BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023

By: GlobeNewswire - 24 Apr 2024

Related companies: BioSenic SA

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

By: GlobeNewswire - 24 Apr 2024

Related companies: Ipsen SA

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

By: GlobeNewswire - 24 Apr 2024

Related companies: Pharming Group N.V.

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

By: PR Newswire Association LLC. - 24 Apr 2024

GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery

By: PR Newswire Association LLC. - 24 Apr 2024

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

By: PR Newswire Association LLC. - 24 Apr 2024

Glycated Albumin Assay Market Projected to Reach $360.92 million by 2030 - Exclusive Report by 360iResearch

By: PR Newswire Association LLC. - 24 Apr 2024

Green Water Labs to Host Community Clean-Up Event in Celebration of Earth Day 2024

By: GlobeNewswire - 24 Apr 2024

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting

By: PR Newswire Association LLC. - 24 Apr 2024

Related companies: Astellas Pharma Inc.

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor

By: GlobeNewswire - 23 Apr 2024

Related companies: Day One Biopharmaceuticals, Inc.

Pennant Announces First Quarter 2024 Earnings Release and Call

By: GlobeNewswire - 23 Apr 2024

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

By: GlobeNewswire - 23 Apr 2024

Related companies: Seer, Inc.

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

By: GlobeNewswire - 23 Apr 2024

Related companies: ClearPoint Neuro, Inc.

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

By: GlobeNewswire - 23 Apr 2024

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

By: GlobeNewswire - 23 Apr 2024

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

By: GlobeNewswire - 23 Apr 2024

Related companies: Shuttle Pharmaceuticals

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

By: GlobeNewswire - 23 Apr 2024

Related companies: OpGen, Inc.

Results 261 - 280 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »